An interventional study of Continuous Positive Pressure in Down Syndrome and Obstructive Sleep Apnea Syndrome, sponsored by Institut Jerome Lejeune. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-03-26.
Sponsored by Institut Jerome Lejeune · Not applicable, Interventional, and Treatment
The purpose of this study is to evaluate the efficacy and tolerability of Continuous Positive Pressure for SAOS in Down Syndrome patients.
1,422 studies on the registry are indexed under Apnea; 159 are open to participants now.
This study's enrollment of 31 is below the median of 50 across 965 interventional studies indexed under Apnea.
Browse Apnea studies →Institut Jerome Lejeune is the lead sponsor of 10 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Night time device for positive pulmonary pressure
Device: Continuous Positive Pressure
Nighttime continuous positive pressure device, to be used every day
Scores on psychometrical and dementia scales after a 3-month treatment period (and if possible, after 12 months)
Time frame: 0 and 3 months
Tolerability
Time frame: 0, 3 and 12 months
This study is completed, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut Jerome Lejeune